Abstract
Chronic spontaneous urticaria is characterized by recurrent itchy wheals. First-line management is with H1-antihistamines. We sought to conduct a Cochrane Review of H1-antihistamines in the treatment of chronic spontaneous urticaria. A systematic search of major databases for randomized controlled trials was conducted. We included 73 studies with 9759 participants; 34 studies provided outcome data for 23 comparisons. Compared with placebo, cetirizine 10mg daily in the short and intermediate term (RR 2.72; 95% confidence interval [CI] 1.51-4.91) led to complete suppression of urticaria. Levocetirizine 20mg daily was effective for short-term use (RR 20.87; 95% CI 1.37-317.60) as was 5mg for intermediate-term use (RR 52.88; 95% CI 3.31-843.81). Desloratadine 20mg was effective for the short term (RR 15.97; 95% CI 1.04-245.04) as was 5mg in the intermediate term (RR 37.00; 95% CI 2.31-593.70). There was no evidence to suggest difference in adverse event rates between treatments. Some methodological limitations were observed. Few studies for each comparison reported outcome data that could be incorporated in meta-analyses. At standard doses, several antihistamines are effective and safe in complete suppression of chronic spontaneous urticaria. Research on long-term treatment using standardized outcome measures and quality of life scores is needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
